XML 46 R24.htm IDEA: XBRL DOCUMENT
v3.22.4

Junior Subordinated Debt Securities | 12 Months Ended
--- | ---
Dec. 31, 2022
Junior Subordinated Notes [Abstract] |
Junior Subordinated Debt Securities | 15. Junior Subordinated Debt Securities Outstanding Junior Subordinated Debt Securities Outstanding junior subordinated debt securities and exchangeable surplus trust securities which are exchangeable for junior subordinated debt securities prior to redemption or repayment, were as follows:
|  |  |  |  |  |  |  |  |  |  |  | December 31,
|  |  |  |  |  |  |  |  |  |  |  | 2022 |  | 2021
Issuer |  | Issue Date |  | Interest Rate (1) |  | Scheduled Redemption Date |  | Interest Rate Subsequent to Scheduled Redemption Date (2) |  | Final Maturity |  | Face Value |  | Unamortized Discount and Issuance Costs |  | Carrying Value |  | Face Value |  | Unamortized Discount and Issuance Costs |  | Carrying Value
|  |  |  |  |  |  |  |  |  |  |  | (In millions)
MetLife, Inc. |  | December 2006 |  | 6.400% |  | December 2036 |  | LIBOR + 2.205% |  | December 2066 |  | $ | 1,250 |  |  | $ | (15) |  |  | $ | 1,235 |  |  | $ | 1,250 |  |  | $ | (16) |  |  | $ | 1,234 |
MetLife Capital Trust IV (3) |  | December 2007 |  | 7.875% |  | December 2037 |  | LIBOR + 3.960% |  | December 2067 |  | 700 |  |  | (13) |  |  | 687 |  |  | 700 |  |  | (13) |  |  | 687 |
MetLife, Inc. |  | April 2008 |  | 9.250% |  | April 2038 |  | LIBOR + 5.540% |  | April 2068 |  | 750 |  |  | (9) |  |  | 741 |  |  | 750 |  |  | (9) |  |  | 741 |
MetLife, Inc. |  | July 2009 |  | 10.750% |  | August 2039 |  | LIBOR + 7.548% |  | August 2069 |  | 500 |  |  | (5) |  |  | 495 |  |  | 500 |  |  | (6) |  |  | 494 |
Total |  |  |  |  |  |  |  |  |  |  |  | $ | 3,200 |  |  | $ | (42) |  |  | $ | 3,158 |  |  | $ | 3,200 |  |  | $ | (44) |  |  | $ | 3,156 |
_________________ (1)Prior to the scheduled redemption date, interest is payable semiannually in arrears. (2)In the event the securities are not redeemed on or before the scheduled redemption date, interest will accrue after such date at an annual rate of three-month LIBOR plus the indicated margin, payable quarterly in arrears. On March 5, 2021, the Intercontinental Exchange Benchmark Administration, the administrator of LIBOR, announced that it will cease the publication of three-month U.S. Dollar LIBOR at the end of June 2023. Existing contract fallback provisions, and whether, how, and when the Company develops and adopts alternative reference rates, will influence the effect of any changes to or discontinuation of LIBOR on the Company. (3)MetLife Capital Trust IV is a VIE which is consolidated on the financial statements of the Company. The securities issued by this entity are exchangeable surplus trust securities, which are exchangeable for a like amount of MetLife, Inc.’s junior subordinated debt securities on the scheduled redemption date, mandatorily under certain circumstances, and at any time upon MetLife, Inc. exercising its option to redeem the securities. In connection with each of the securities described above, MetLife, Inc. may redeem or may cause the redemption of the securities (i) in whole or in part, at any time on or after the date five years prior to the scheduled redemption date at their principal amount plus accrued and unpaid interest to, but excluding, the date of redemption, or (ii) in certain circumstances, in whole or in part, prior to the date five years prior to the scheduled redemption date at their principal amount plus accrued and unpaid interest to, but excluding, the date of redemption or, if greater, a make-whole price. MetLife, Inc. also has the right to, and in certain circumstances the requirement to, defer interest payments on the securities for a period up to 10 years. Interest compounds during such periods of deferral. If interest is deferred for more than five consecutive years, MetLife, Inc. is required to use proceeds from the sale of its common stock or warrants on common stock to satisfy this interest payment obligation. In connection with each of the securities described above, MetLife, Inc. entered into a separate replacement capital covenant (“RCC”). As part of each RCC, MetLife, Inc. agreed that it will not repay, redeem, or purchase the securities on or before a date 10 years prior to the final maturity date of each issuance, unless, subject to certain limitations, it has received cash proceeds during a specified period from the sale of specified replacement securities. Each RCC will terminate upon the occurrence of certain events, including an acceleration of the applicable securities due to the occurrence of an event of default. The RCCs are not intended for the benefit of holders of the securities and may not be enforced by them. Rather, each RCC is for the benefit of the holders of a designated series of MetLife, Inc.’s other indebtedness (the “Covered Debt”). Initially, the Covered Debt for each of the securities described above was MetLife, Inc.’s 5.700% senior notes due 2035 (the “5.700% Senior Notes”). As a result of the issuance of MetLife, Inc.’s 10.750% Fixed-to-Floating Rate Junior Subordinated Debentures due 2069 (the “10.750% JSDs”), the 10.750% JSDs became the Covered Debt with respect to, and in accordance with, the terms of the RCC relating to MetLife, Inc.’s 6.40% Fixed-to-Floating Rate Junior Subordinated Debentures due 2066. The 5.700% Senior Notes continue to be the Covered Debt with respect to, and in accordance with, the terms of the RCCs relating to each of MetLife Capital Trust IV’s 7.875% Fixed-to-Floating Rate Exchangeable Surplus Trust Securities, MetLife, Inc.’s 9.250% Fixed-to-Floating Rate Junior Subordinated Debentures and the 10.750% JSDs. MetLife, Inc. also entered into a replacement capital obligation which will commence during the six-month period prior to the scheduled redemption date of each of the securities described above and under which MetLife, Inc. must use reasonable commercial efforts to raise replacement capital to permit repayment of the securities through the issuance of certain qualifying capital securities. Interest expense on outstanding junior subordinated debt securities was $261 million for each of the years ended December 31, 2022, 2021 and 2020, which is included in other expenses.

X
- Definition This element may be used as a single block of text to encapsulate the entire disclosure for Junior Subordinated Debt Securities borrowings including data and tables. + References No definition available. + Details
Name: | met_JuniorSubordinatedDebtSecuritiesTextBlock
Namespace Prefix: | met_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_JuniorSubordinatedLongtermNotesCurrentAndNoncurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration